These RNAs constitute a network that regulates the epithelial–mesenchymal transition (EMT) with p53, promoting an epithelial gene expression program in breast cancer, e.g., through the targeting of ZEB1/2 EMT transcription factors [23]. Here, TP53 is linked to breast cancer.